Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis.

Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. · 2020

Read Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. by Richardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7089422.txt.

Description

Richardson and co-authors use genetics to ask which blood lipids really cause coronary heart disease. Their study appeared in PLoS Medicine. They ran a genome study in UK Biobank, then applied Mendelian randomisation with data on 60,801 heart disease cases and 123,504 controls.

Taken alone, LDL cholesterol, triglycerides, and apolipoprotein B each linked to higher risk. When the traits were judged together, only apolipoprotein B kept a strong effect. Higher HDL cholesterol and apolipoprotein A-I looked protective alone, but faded once apolipoprotein B was counted. The authors argue that apolipoprotein B best captures the harm from these particles. Readers get a clear case for focusing drug targets and tests on that measure.

Catalog record

CREATORRichardson TG, Sanderson E, Palmer TM, Ala-Korpela M, Ference BA, Davey Smith G, Holmes MV.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE75 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7089422

Browse the full library · About the Tower of Babel